Literature DB >> 6187005

Use of monoclonal antibodies to identify shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus.

G Solomon, J Schiffenbauer, H D Keiser, B Diamond.   

Abstract

Antinative DNA antibodies were purified from the serum of a patient with active systemic lupus erythematosus. Using hybridoma technology, we produced several mouse monoclonal antibodies directed against idiotypic determinants on these antinative DNA antibodies. One of these monoclonal anti-idiotypic antibodies, 3I, an IgG2a Kappa, was extensively characterized. 3I is believed to be directed against an idiotypic determinant because (i) its reactivity with antinative DNA antibodies is not inhibited by a large excess of pooled human serum, (ii) it reacts with F(ab')2 fragments of antinative DNA antibodies, and (iii) it reacts with antinative DNA antibodies of all IgG subclasses. 3I is not directed against the antigen binding site in that native DNA and 3I do not compete for binding to antinative DNA antibodies. Eight of nine sera containing antinative DNA activity as determined by the Millipore filter assay reacted with 3I in a solid-phase radioimmunoassay. These findings suggest that antinative DNA antibodies from nonrelated patients with systemic lupus erythematosus share a common idiotype.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187005      PMCID: PMC393478          DOI: 10.1073/pnas.80.3.850

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Preparation of 125I-labeled native DNA for use in radioimmunoassays for anti-native-DNA antibodies.

Authors:  H Keiser
Journal:  Arthritis Rheum       Date:  1973 Jul-Aug

3.  A Millipore filter assay for antibodies to native DNA in sera of patients with systemic lupus erythematosus.

Authors:  B Ginsberg; H Keiser
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

4.  Antigenic specificities related to the cold agglutinin activity of gamma M globulins.

Authors:  R C Willims; H G Kunkel; J D Capra
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

5.  Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment.

Authors:  M Potter; J G Pumphrey; J L Walters
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

6.  Production of monoclonal murine antibodies to DNA by somatic cell hybrids.

Authors:  B H Hahn; F Ebling; S Freeman; B Clevinger; J Davie
Journal:  Arthritis Rheum       Date:  1980-08

7.  The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies.

Authors:  B Diamond; B R Bloom; M D Scharff
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

8.  Cloning of mouse myeloma cells and detection of rare variants.

Authors:  P Coffino; R Baumal; R Laskov; M D Scharff
Journal:  J Cell Physiol       Date:  1972-06       Impact factor: 6.384

9.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells.

Authors:  M L Gefter; D H Margulies; M D Scharff
Journal:  Somatic Cell Genet       Date:  1977-03

10.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  42 in total

1.  Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanisms.

Authors:  F Shokri; R A Mageed; G D Kitas; P Katsikis; H M Moutsopoulos; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Idiotype usage by polyclonally activated B cells in experimental autoimmunity and infection.

Authors:  M Sutmuller; J J Baelde; M P Madaio; J A Bruijn; E De Heer
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 3.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 4.  The idiotype-antiidiotype network in human autoimmunity.

Authors:  N I Abdou
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

5.  Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype.

Authors:  A Manheimer-Lory; J B Katz; M Pillinger; C Ghossein; A Smith; B Diamond
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

6.  A common anti-cardiolipin antibody idiotype in autoimmune disease: identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibody.

Authors:  M Sutjita; A Hohmann; R Comacchio; M L Boey; J Bradley
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

7.  Expression of an interspecies idiotype in sera of SLE patients and their first-degree relatives.

Authors:  H Dang; M Takei; D Isenberg; Y Shoenfeld; R Backimer; J Rauch; N Talal
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

8.  Autoantibodies in systemic lupus erythematosus and normal subjects.

Authors:  E Pateraki; E Kaklamani; P Kaklamanis; R Portocalas; A Aessopos
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

9.  High frequency of autoantibodies bearing cross-reactive idiotopes among hybridomas using VH7183 genes prepared from normal and autoimmune murine strains.

Authors:  B Bellon; A Manheimer-Lory; M Monestier; T Moran; A Dimitriu-Bona; F Alt; C Bona
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

10.  Crossreactivity and inheritance of idiotypes restricted to human anti-tetanus toxoid antibodies.

Authors:  C M Brozek; R S Geha
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.